Adenosine Phosphate

Adenosine Phosphate

SCHEMBL2406483

NC(CC(=O)O)C(=O)O.Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC6A2SLC6A3

The experimentally established mechanism targets of Adenosine Phosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY1 P47900 5/20 0.81
P2RY2 P41231 3/20 0.81
SRC P12931 2/20 0.81
SMN1; SMN2 Q16637 2/20 0.81
TRPM2 O94759 2/20 0.81
TAS1R3 Q7RTX0 2/20 0.81
TAS1R1 Q7RTX1 2/20 0.81
DNPH1 O43598 1/20 0.81
PRKAB2 O43741 1/20 0.81
LDHA P00338 1/20 0.81
ADRB2 P07550 1/20 0.81
FBP1 P09467 1/20 0.81
ADORA1 P30542 1/20 0.81
PRKAG1 P54619 1/20 0.81
PRKAA2 P54646 1/20 0.81
PDE4D Q08499 1/20 0.81
KCNH2 Q12809 1/20 0.81
PRKAA1 Q13131 1/20 0.81
PDE3A Q14432 1/20 0.81
P2RY11 Q96G91 1/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adenosine Phosphate SCHEMBL15671039 0.94 P2RY1 (0.80) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL3514918 0.92 P2RY1 (0.76) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL15670765 0.92 P2RY1 (0.68) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL15670584 0.92 P2RY1 (0.78) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL15670779 0.91 P2RY1 (0.80) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL9455662 0.90 P2RY1 (0.85) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL20304185 0.90 P2RY1 (0.89) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL3291177 0.90 P2RY1 (0.89) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL790420 0.90 P2RY1 (0.92) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL1331852 0.90 P2RY1 (0.76) P2RY1P2RY2SRCSMN1; SMN2TRPM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11253595-B2 Treatment for reducing adverse events including chemotherapy discomfort and other conditions Siamon, Al (US) 2022-02-22 US disclosed
US-20210213131-A1 TREATMENT FOR REDUCING ADVERSE EVENTS INCLUDING CHEMOTHERAPY DISCOMFORT AND OTHER CONDITIONS SIAMON AL (US) 2021-07-15 US disclosed
US-20210154225-A1 TREATMENT FOR REDUCING ADVERSE EVENTS INCLUDING CHEMOTHERAPY DISCOMFORT AND OTHER CONDITIONS SIAMON AL (US) 2021-05-27 US disclosed
WO-2021102326-A1 TREATMENT FOR REDUCING ADVERSE EVENTS INCLUDING CHEMOTHERAPY DISCOMFORT AND OTHER CONDITIONS SIAMON AL (US) 2021-05-27 WO disclosed
US-11000540-B1 Treatment for reducing adverse events including chemotherapy discomfort and other conditions SIAMON AL (US) 2021-05-11 US disclosed
US-10722562-B2 Combinatorial analysis and repair IMMUDEX APS (DK) 2020-07-28 US disclosed
EP-2914132-A1 FLAVOUR ADDITIVES Mars, Incorporated (US) 2015-09-09 EP disclosed
WO-2014068045-A1 FLAVOUR ADDITIVES MARS, INCORPORATED (US) 2014-05-08 WO disclosed
US-20110212090-A1 Combinatorial Analysis and Repair DAKO DENMARK A/S 2011-09-01 US disclosed
WO-2010009735-A2 COMBINATORIAL ANALYSIS AND REPAIR DAKO DENMARK A/S (DK) 2010-01-28 WO disclosed